These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7505985)

  • 1. Future directions in tumor marker technology for prostate cancer.
    Smith JA; Scaletsky R
    Urol Clin North Am; 1993 Nov; 20(4):771-7. PubMed ID: 7505985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers].
    Zlotta A; Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A201-5. PubMed ID: 10523893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI
    Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer].
    Otnes B; Hernes E; Fosså SD
    Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3401-5. PubMed ID: 9800488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers.
    Schellhammer PF; Wright GL
    Urol Clin North Am; 1993 Nov; 20(4):597-606. PubMed ID: 7505967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
    Lin DW
    Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The search for better markers for prostate cancer than prostate-specific antigen].
    Schenk-Braat EA; Bangma CH
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF; Mensink HJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of prostate specific antigen. A review].
    Brasso K; Skaarup P; Roosen JU; Iverson P
    Ugeskr Laeger; 1998 Jul; 160(31):4510-6. PubMed ID: 9700305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)].
    Tsuchiya N; Ohyama C; Habuchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):275-80. PubMed ID: 15751649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical profiles of prostate cancer in our hospital: association between primary symptoms and clinical stage].
    Kimura T; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2000 Feb; 46(2):83-6. PubMed ID: 10769794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is prostate-specific antigen still the best tumor marker for prostate cancer?
    Leewansangtong S; Soontrapa S; Tantiwong A
    J Med Assoc Thai; 1999 Oct; 82(10):1034-40. PubMed ID: 10561969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.
    Stephan C; Jung K; Lein M; Sinha P; Schnorr D; Loening SA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1133-47. PubMed ID: 11097220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
    Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
    Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostatic specific antigen: role and significance in urologic practice].
    Manolović D; Pejcić T; Milović N
    Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPM3: review of a new molecular diagnostic urine test for prostate cancer.
    Saad F
    Can J Urol; 2005 Feb; 12 Suppl 1():40-3; discussion 99-100. PubMed ID: 15780164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostate cancer].
    Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.